Erik A. A. Wallén

1.2k citations

46 papers · 1.1k indexed · h-index 20

Molecular Biology
Organic Chemistry top 5%
Oncology top 10%
Cellular and Molecular Neuroscience top 10%
Geriatrics and Gerontology top 2%

Co-authors: Elina M. Jarho Pekka T. Männistö Jarkko I. Venäläinen Kristina Luthman Jukka Gynther Markus Forsberg Johannes A. M. Christiaans Morten Grøtli
Topics: Peptidase Inhibition and Analysis (23 papers)Neuropeptides and Animal Physiology (12 papers)Chemical Synthesis and Analysis (8 papers)
Cited by: Geriatrics and Gerontology Physiology Organic Chemistry
Journals: Biochemical Journal Journal of Medicinal Chemistry The Journal of Organic Chemistry
Partner nations: Finland Sweden Denmark

In The Last Decade

Erik A. A. Wallén

46 papers receiving 1.0k citations

Peers

Countries citing papers authored by Erik A. A. Wallén

Since Specialization

Citations

This map shows the geographic impact of Erik A. A. Wallén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik A. A. Wallén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik A. A. Wallén more than expected).

Fields of papers citing papers by Erik A. A. Wallén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik A. A. Wallén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik A. A. Wallén. The network helps show where Erik A. A. Wallén may publish in the future.

Co-authorship network of co-authors of Erik A. A. Wallén

This figure shows the co-authorship network connecting the top 25 collaborators of Erik A. A. Wallén. A scholar is included among the top collaborators of Erik A. A. Wallén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik A. A. Wallén. Erik A. A. Wallén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Azulene as a biphenyl mimetic in orexin/hypocretin receptor agonists 2023 ·Bioorganic & Medicinal Chemistry ·(unknown),Ainoleena Turku,(unknown),(unknown),(unknown),(unknown),Jari Yli‐Kauhaluoma,Henri Xhaard,Jyrki P. Kukkonen,Erik A. A. Wallén	1
2	2-Imidazole as a Substitute for the Electrophilic Group Gives Highly Potent Prolyl Oligopeptidase Inhibitors 2021 ·ACS Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),(unknown),(unknown),Maija Lahtela‐Kakkonen,Timo T. Myöhänen,Erik A. A. Wallén	6
3	The effect of prolyl oligopeptidase inhibitors on alpha-synuclein aggregation and autophagy cannot be predicted by their inhibitory efficacy 2020 ·Biomedicine & Pharmacotherapy ·(unknown),Laura Hellinen,(unknown),Yan Xu,(unknown),Kati‐Sisko Vellonen,Anne‐Marie Lambeir,Henri J. Huttunen,Arto Urtti,Erik A. A. Wallén,Timo T. Myöhänen	23
4	A scaffold replacement approach towards new sirtuin 2 inhibitors 2019 ·Bioorganic & Medicinal Chemistry ·Tina Seifert,Marcus Malo,Tarja Kokkola,E. Johanna L. Stéen,(unknown),Erik A. A. Wallén,Elina M. Jarho,Kristina Luthman	11
5	Pharmacological characterization of the orexin/hypocretin receptor agonist Nag 26 2018 ·European Journal of Pharmacology ·(unknown),(unknown),Ainoleena Turku,Pauli M. Turunen,(unknown),Henri Xhaard,Erik A. A. Wallén,Jyrki P. Kukkonen	12
6	Stapled truncated orexin peptides as orexin receptor agonists 2018 ·Peptides ·(unknown),Janne Weisell,Pauli M. Turunen,(unknown),(unknown),Henri Xhaard,Jyrki P. Kukkonen,Erik A. A. Wallén	8
7	Chroman-4-one and chromone based somatostatin β-turn mimetics 2016 ·European Journal of Medicinal Chemistry ·Maria Fridén‐Saxin,Tina Seifert,Marcus Malo,(unknown),Nils Pemberton,Christine Dyrager,Annika Friberg,(unknown),Erik A. A. Wallén,Morten Grøtli,Kristina Luthman	12
8	Synthesis and biological evaluation of novel 123I-labeled 4-(4-iodophenyl)butanoyl-l-prolyl-(2S)-pyrrolidines for imaging prolyl oligopeptidase in vivo 2014 ·European Journal of Medicinal Chemistry ·(unknown),(unknown),Roope A. Kallionpää,Susanne Bäck,Mirkka Sarparanta,Mari Raki,J. Arturo García‐Horsman,Kim Bergström,Erik A. A. Wallén,Pekka T. Männistö,Anu J. Airaksinen	2
9	Chroman-4-one- and Chromone-Based Sirtuin 2 Inhibitors with Antiproliferative Properties in Cancer Cells 2014 ·Journal of Medicinal Chemistry ·Tina Seifert,Marcus Malo,Tarja Kokkola,(unknown),Maria Fridén‐Saxin,Erik A. A. Wallén,Maija Lahtela‐Kakkonen,Elina M. Jarho,Kristina Luthman	108
10	Inhibitors and promoters of tubulin polymerization: Synthesis and biological evaluation of chalcones and related dienones as potential anticancer agents 2011 ·Bioorganic & Medicinal Chemistry ·Christine Dyrager,Malin Wickström,Maria Fridén‐Saxin,Annika Friberg,(unknown),Erik A. A. Wallén,Joachim Gullbo,Morten Grøtli,Kristina Luthman	61
11	Mimetics of the disulfide bridge between the N- and C-terminal cysteines of the KLK3-stimulating peptide B-2 2009 ·Amino Acids ·(unknown),Janne Weisell,Can Hekim,Jouko Vepsäläinen,Erik A. A. Wallén,Ulf‐Håkan Stenman,Hannu Koistinen,Ale Närvänen	11
12	Characterization of the binding properties of SIRT2 inhibitors with a N-(3-phenylpropenoyl)-glycine tryptamide backbone 2008 ·Bioorganic & Medicinal Chemistry ·(unknown),(unknown),Jukka Leppänen,Valtteri Rinne,Sergiy Kyrylenko,Erkki Kuusisto,Tiina Suuronen,Antero Salminen,Antti Poso,Maija Lahtela‐Kakkonen,Erik A. A. Wallén	20
13	Oxadiazole-carbonylaminothioureas as SIRT1 and SIRT2 Inhibitors 2008 ·Journal of Medicinal Chemistry ·(unknown),Tiina Suuronen,Valtteri Rinne,Carsten Wittekindt,Maija Lahtela‐Kakkonen,Elina M. Jarho,Erik A. A. Wallén,Antero Salminen,Antti Poso,Jukka Leppänen	66
14	N-(3-(4-Hydroxyphenyl)-propenoyl)-amino acid tryptamides as SIRT2 inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Jukka Leppänen,Valtteri Rinne,Tiina Suuronen,(unknown),Sergiy Kyrylenko,Erkki Kuusisto,Anu J. Tervo,Tomi Järvinen,Antero Salminen,Antti Poso,Erik A. A. Wallén	42
15	An introduction of a pyridine group into the structure of prolyl oligopeptidase inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Elina M. Jarho,Jarkko I. Venäläinen,(unknown),(unknown),Jouko Vepsäläinen,Johannes A. M. Christiaans,Markus Forsberg,Tomi Järvinen,Pekka T. Männistö,Erik A. A. Wallén	8
16	Binding kinetics and duration of in vivo action of novel prolyl oligopeptidase inhibitors 2006 ·Biochemical Pharmacology ·Jarkko I. Venäläinen,J. Arturo García‐Horsman,Markus Forsberg,Aaro J. Jalkanen,Erik A. A. Wallén,Elina M. Jarho,Johannes A. M. Christiaans,Jukka Gynther,Pekka T. Männistö	60
17	Beneficial Effect of Prolyl Oligopeptidase Inhibition on Spatial Memory in Young but Not in Old Scopolamine‐Treated Rats 2006 ·Basic & Clinical Pharmacology & Toxicology ·Aaro J. Jalkanen,Katja A. Puttonen,Jarkko I. Venäläinen,(unknown),Anne Mannila,Sirja Ruotsalainen,Elina M. Jarho,Erik A. A. Wallén,Pekka T. Männistö	41
18	Synthesis of 2,3,6,8-Tetrasubstituted Chromone Scaffolds 2006 ·The Journal of Organic Chemistry ·(unknown),Erik A. A. Wallén,Morten Grøtli,Kristina Luthman	49
19	Substrate-dependent, non-hyperbolic kinetics of pig brain prolyl oligopeptidase and its tight binding inhibition by JTP-4819 2002 ·Biochemical Pharmacology ·Jarkko I. Venäläinen,Risto O. Juvonen,Markus Forsberg,J. Arturo García‐Horsman,Antti Poso,Erik A. A. Wallén,Jukka Gynther,Pekka T. Männistö	51
20	4-Phenylbutanoyl-2(S)-acylpyrrolidines and 4-phenylbutanoyl-l-prolyl-2(S)-acylpyrrolidines as prolyl oligopeptidase inhibitors 2002 ·Bioorganic & Medicinal Chemistry ·Erik A. A. Wallén,Johannes A. M. Christiaans,Susanna M. Saario,Markus Forsberg,Jarkko I. Venäläinen,(unknown),Pekka T. Männistö,Jukka Gynther	34

About Erik A. A. Wallén

Erik A. A. Wallén is a scholar working on Geriatrics and Gerontology, Physiology and Oncology, having authored 46 papers that have together received 1.1k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (23 papers), Neuropeptides and Animal Physiology (12 papers) and Chemical Synthesis and Analysis (8 papers). The work is most often cited by research in Geriatrics and Gerontology (154 citations), Physiology (115 citations) and Organic Chemistry (437 citations). Erik A. A. Wallén has collaborated with scholars based in Finland, Sweden and Denmark. Frequent co-authors include Elina M. Jarho, Pekka T. Männistö, Jarkko I. Venäläinen, Kristina Luthman, Jukka Gynther, Markus Forsberg, Johannes A. M. Christiaans, Morten Grøtli, Antti Poso and Maija Lahtela‐Kakkonen. Their work appears in journals such as Biochemical Journal, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact